{"company":{"id":3780299,"name":"KSQ Therapeutics","domain":"ksqtx.com","url":"https://alion.io/company/ksqtx"},"section":"news","answer":"KSQ Therapeutics: 40 headlines on record, 0 headlines in the last 90 days. Its story counts 6 milestones.","figures":[{"label":"Headlines","value":"40"},{"label":"In 90 days","value":"0"},{"label":"Milestones","value":"6"}],"blocks":[{"key":"story","title":"Milestones","source":"Each milestone is dated by its source: registers, filings, the press","rows":6}],"story":[{"title":"Board appointment KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors · ksqtx.com","url":"https://ksqtx.com/press-releases/ksq-therapeutics-appoints-kristen-hege-m-d-to-its-board-of-directors/"},{"title":"Board appointment KSQ Therapeutics Appoints John Lepore, M.D., to its Board of Directors · ksqtx.com","url":"https://ksqtx.com/press-releases/ksq-therapeutics-appoints-john-lepore-m-d-to-its-board-of-directors/"},{"title":"Certified KSQ Therapeutics Announces FDA Clearance of IND Application for KSQ-004EX, a CRISPR/Cas9 Engineered Tumor-Infiltrating Lymphocyte (eTIL) Therapy · ksqtx.com","url":"https://ksqtx.com/press-releases/ksq-therapeutics-announces-fda-clearance-of-ind-application-for-ksq-004ex-a-crispr-cas9-engineered-tumor-infiltrating-lymphocyte-etil-therapy/"},{"title":"Board appointment KSQ Therapeutics Appoints Richard Moscicki, MD, to Board of Directors · ksqtx.com","url":"https://ksqtx.com/press-releases/ksq-therapeutics-appoints-richard-moscicki-md-to-board-of-directors/"},{"title":"Raised a round Venture round $80M","url":"https://ksqtx.com/press-releases/ksq-therapeutics-secures-80-million-financing-and-advances-broad-pipeline-of-cancer-therapies-including-its-first-adoptive-t-cell-therapy-program-for-pd-1-resistant-solid-tumors/"},{"title":"Website went live first capture in the Wayback Machine","url":"https://web.archive.org/web/20151205074115/ksqtx.com"}],"as_of":"2026-11-22","cite":"KSQ Therapeutics, News. Alion, Nov 22, 2026. https://alion.io/company/ksqtx/news","html_url":"https://alion.io/company/ksqtx/news","json_url":"https://alion.io/company/ksqtx/news.json","license":"CC BY-SA 4.0","meta":{"source":"Alion","generated_at":"2026-11-22T08:07:43Z"}}